- Home
- What We Do
- Investment Banking
- Transactions
Transactions
Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

US$140m
February 2021
Yellow Cake plc
Nomad and Joint Bookrunner (Fundraise)
METALS AND MINING
EQUITY CAPITAL MARKETS
CORPORATE BROKING
JERSEY
View transaction detail

US$186m
February 2021
TheScore
Joint Bookrunner (US IPO)
TECHNOLOGY
EQUITY CAPITAL MARKETS
CANADA

US$1b
February 2021
Dropbox, Inc.
Co-Manager (144a Convert)
TECHNOLOGY
EQUITY CAPITAL MARKETS
US

US$230m
February 2021
Velocity Acquisition Corp.
Joint Bookrunner (IPO)
SPACS
EQUITY CAPITAL MARKETS
US

US$1b
February 2021
MicroStrategy Incorporated
Co-Manager (144a Convert)
TECHNOLOGY
EQUITY CAPITAL MARKETS
US

US$175m
February 2021
Travere Therapeutics Inc.
Lead Manager (Follow-on)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail

US$69m
February 2021
Kaledio
Lead Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail

£422m
February 2021
Jet2.com
Joint Global Coordinator, Joint Bookrunner and Joint Broker (Placing and Retail Offer)
INDUSTRIALS/AEROSPACE & DEFENSE
AEROSPACE & DEFENCE
CORPORATE BROKING
EQUITY CAPITAL MARKETS
UK

US$120m
February 2021
Bioventus Inc.
Lead Manager (IPO)
HEALTHCARE
EQUITY CAPITAL MARKETS
US

US$288m
February 2021
Viant Technology, Inc.
Co-Manager (IPO)
TECHNOLOGY
EQUITY CAPITAL MARKETS
US

US$101m
February 2021
The ExOne Company
Joint Bookrunner (CMPO)
SUSTAINABILITY
INDUSTRIALS/AEROSPACE & DEFENSE
EQUITY CAPITAL MARKETS
US

US$173m
February 2021
Rhythm Pharmaceuticals, Inc.
Lead Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail